Crowdonomics
WatchlistPortfolio
Arcade Therapeutics

Reg CF · SAFE · Oct 2024

ClosedReached targetReg CFSAFE
via WeFunderView campaign
Raised
$795.6K / $1.2M max
64% of ceiling · target hit day 4
Investors
18
$44.2K avg
Valuation cap
$12.5M
cap, not an agreed valuation

Raised over time

Cumulative raisedInvestors
$796K$398K$0
1890
Oct 28, 2024 · openedApr 30, 2025 · last reading
Target ($50K) hit — Nov 1, 2024, day 4Deadline Apr 30, 2025 — 0 days out

Left axis: cumulative dollars raised. Right axis: cumulative investors. Live figures via WeFunder; investor counts may lag the platform by up to a day.

Financials disclosed in this offering

FY2022–FY2023 · hover for source
$0
−$1.0M
FY2022
$0
−$1.2M
FY2023
RevenueNet income
Metric
FY2022 reviewed
FY2023 reviewed
Income statement
Revenue
$0
$0
Cost of goods sold
$0
$0
Net income
-$1,017,002
-$1,183,271
Taxes paid
$0
$0
Balance sheet
Cash
$438,634
$36,510
Accounts receivable
$0
$0
Total assets
$450,073
$46,510
Short-term debt
$93,759
$313,466
Long-term debt
$1,270,000
$1,830,000
Total liabilities
$1,363,759
$2,143,466
Other
Headcount
—
3

The fiscal years the issuer disclosed in this offering’s filing, as filed. Full history on the company page.

Deal terms

Valuation cap$12.5M ($10M early bird)

Perks

First $350K of investments will be in a safe with a $10M valuation cap and 20% discountfirst $350K

Offering details

Target$50,000
Max$1,235,000
Min investment$250
OpenedOct 28, 2024
DeadlineApr 30, 2025
ClosedApr 30, 2025
Days active184

Links & provenance

Campaign pageSEC filing
Source: Manual
0001670254-24-000815

About this data. Raised amounts and investor counts come from the platform listing and may lag or be restated; SEC-reported totals can differ until the next Form 1-Z/C-U. Post-money valuation is computed as pre-money plus amount raised and is shown once the round closes — it is not a traded price. Financial statements are as reported by the issuer. Crowdonomics is not a broker-dealer, funding portal, or investment adviser; nothing here is investment advice or an offer to sell securities. Verify all figures against the linked EDGAR filings.